KLRC2 and glioblastoma: Indeed, additional experiments verified that IL-2 increased the expression of CD335/NKp46, CD336/NKp44, CD337/NKp30, CD314/NKG2D and CD159c/NKG2C on GBM-derived CD158ab+ NK-cells (Suppl.